Detection and Grading of Soft Tissue Sarcomas of the Extremities with 18F-3′-Fluoro-3′-Deoxy-L-Thymidine

Clinical Cancer Research

Volumn 10, Issue 5, 2004, Pages 1685-1690

  Cobben, David C P ^a   Elsinga, Philip H ^a   Suurmeijer, Albert J H ^a   Vaalburg, Wim ^a   Maas, Bram ^a   Jager, Piet L ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; 3' FLUOROTHYMIDINE F 18; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LIMB TUMOR; MALE; MITOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOFT TISSUE SARCOMA;

AGED; DIDEOXYNUCLEOSIDES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SARCOMA; SOFT TISSUE NEOPLASMS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1842481203     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0040     Document Type: Article

References (40)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics, 2003. CA Cancer J. Clin., 53: 5-26, 2003.
2. Visser, O., Coebergh, J. W. W., van Dijck, J. A. A. M., and Siesling, S. Incidence of Cancer in the Netherlands 1998. Utrecht, the Netherlands: Vereniging van Integrale Kankercentra, 2002.
3. Gustafson, P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop. Scand. Suppl., 259: 1-31, 1994.
4. Nijhuis, P. H., Schaapveld, M., Otter, R., Molenaar, W. M., van der Graaf, W. T., and Hoekstra, H. J. Epidemiological aspects of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials. Eur. J. Cancer, 35: 1705-1710, 1999.
5. Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., Vilain, M. O., Mandard, A. M., Le Doussal, V., Leroux, A., Jacquemier, J., Duplay, H., Sastre-Garau, X.. and Costa, J. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J. Clin. Oncol., 15: 350-362, 1997.
6. Hasegawa, T., Yamamoto, S., Nojima, T., Hirose, T., Nikaido, T., Yamashiro, K., and Matsuno, Y. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum. Pathol., 33: 111-115, 2002.
7. Hasegawa, T., Yokoyama, R., Lee, Y. H., Shimoda, T., Beppu, Y., and Hirohashi, S. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology, 58: 66-74, 2000.
8. Ham, S. J., van der Graaf, W. T., Pras, E., Molenaar, W. M., van den, B. E., and Hoekstra, H. J. Soft tissue sarcoma of the extremities. A multimodality diagnostic and therapeutic approach. Cancer Treat. Rev., 24: 373-391, 1998.
9. Jager, P. L., Hoekstra, H. J., Leeuw, J., Der Graaf, W. T., de Vries, E. G., and Piers, D. A. Routine bone scintigraphy in primary staging of soft tissue sarcoma; is it worthwhile? Cancer (Phila.), 89: 1726-1731, 2000.
10. van Ginkel, R. J., Hoekstra, H. J., Pruim, J., Nieweg, O. E., Molenaar, W. M., Paans, A. M., Willemsen, A. T., Vaalburg, W., and Koops, H. S. FDG-PET to evaluate response to hyperthermic isolated limb, perfusion for locally advanced soft-tissue sarcoma. J. Nucl. Med., 37: 984-990, 1996.
11. 18F]fluorodeoxyglucose. Ann. Surg. Oncol., 4: 57-63, 1997.
12. Plaat, B., Kole, A., Mastik, M., Hoekstra, H., Molenaar, W., and Vaalburg, W. Protein synthesis rate measured with L-[1-11C]tyrosine positron emission tomography correlates with mitotic activity and MIB-1 antibody-detected proliferation in human soft tissue sarcomas. Eur. J. Nucl. Med., 26: 328-332, 1999.
13. Kole, A. C., Plaat, B. E., Hoekstra, H. J., Vaalburg, W., and Molenaar, W. M. FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy. J. Nucl. Med., 40: 381-386, 1999.
14. van Ginkel, R. J., Kole, A. C., Nieweg, O. E., Molenaar, W. M.. Pruim, J., Koops, H. S., Vaalburg, W., and Hoekstra, H. J. L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer. J. Nucl. Med., 40: 262-267, 1999.
15. Schwarzbach, M., Willeke, F., Dimitrakopoulou-Strauss, A., Strauss, L. G., Zhang, Y. M., Mechtersheimer, G., Hinz, U., Lehnert, T., and Herfarth, C. Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography. Anticancer Res., 19: 1343-1349, 1999.
16. Reske, S. N., and Kotzerke, J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III," 21 July and 19 September 2000. Eur. J. Nucl. Med., 28: 1707-1723, 2001.
17. Eary, J. F., Conrad, E. U., Bruckner, J. D., Folpe, A., Hunt, K. J., Mankoff, D. A., and Howlett, A. T. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin. Cancer Res., 4: 1215-1220, 1998.
18. Schulte, M., Brecht-Krauss, D., Heymer, B., Guhlmann, A., Hartwig, E., Sarkar, M. R., Diederichs, C. G., Schultheiss, M., Kotzerke, J., and Reske, S. N. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur. J. Nucl. Med., 26: 599-605, 1999.
19. Schwarzbach, M. H., Dimitrakopoulou-Strauss, A., Willeke, F., Hinz, U., Strauss, L. G., Zhang, Y. M., Mechtersheimer, G., Attigah, N., Lehnert, T., and Herfarth, C. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann. Surg., 231: 380-386, 2000.
20. Garcia, R., Kim, E. E., Wong, F. C., Korkmaz, M., Wong, W. H., Yang, D. J., and Podoloff, D. A. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas. J. Nucl. Med., 37: 1476-1479, 1996.
21. Nieweg, O. E., Pruim, J., van Ginkel, R. J., Hoekstra, H. J., Paans, A. M., Molenaar, W. M., Schraffordt Koops, H. S., and Vaalburg, W. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J. Nucl. Med., 37: 257-261, 1996.
22. Dimitrakopoulou-Strauss, A., Strauss, L. G., Schwarzbach, M., Burger, C., Heichel, T., Willeke, F., Mechtersheimer, G., and Lehnert, T. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading. J. Nucl. Med., 42: 713-720, 2001.
23. Lodge, M. A., Lucas, J. D., Marsden, P. K., Cronin, B. F., O'Doherty, M. J., and Smith, M. A. A PET study of 18FDG uptake in soft tissue masses. Eur. J. Nucl. Med., 26: 22-30, 1999.
24. Schwarzbach, M. H., Dimitrakopoulou-Strauss, A., Mechtersheimer, G., Hinz, U., Willeke, F., Cardona, S., Attigah, N., Strauss, L. G., Herfarth, C., and Lehnert, T. Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET). Anticancer Res., 21: 3609-3614, 2001.
25. Folpe, A. L., Lyles, R. H., Sprouse, J. T., Conrad, E. U., III, and Eary, J. F. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin. Cancer Res., 6: 1279-1287, 2000.
26. Lucas, J. D., O'Doherty, M. J., Wong, J. C., Bingham, J. B., McKee, P. H., Fletcher, C. D., and Smith, M. A. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J. Bone Jt. Surg. Br., 80: 441-447, 1998.
27. Delbeke, D., Martin, W. H., Sandler, M. P., Chapman, W. C., Wright, J. K., Jr., and Pinson, C. W. Evaluation of benign versus malignant hepatic lesions with positron emission tomography. Arch. Surg., 133: 510-515, 1998.
28. Watanabe, H., Shinozaki, T., Yanagawa, T., Aoki, J., Tokunaga, M., Inoue, T., Endo, K., Mohara, S., Sano, K., and Takagishi, K. Glucose metabolic analysis of musculoskeletal tumours using 18-fluorine-FDG PET as an aid to preoperative planning. J. Bone Jt. Surg. Br., 82: 760-767, 2000.
29. Lucas, J. D., O'Doherty, M. J., Cronin, B. F., Marsden, P. K., Lodge, M. A., McKee, P. H., and Smith, M. A. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br. J. Surg., 86: 550-556, 1999.
30. Haberkorn, U. The role of diagnostic PET in treatment planning before tumor surgery (German). Chirurg, 72: 1010-1019, 2001.
31. Ioannidis, J. P., and Lau, J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J. Nucl. Med., 44: 717-724, 2003.
32. Bastiaannet, E., Groen, H., Jager, P. L., Cobben, D. C. P., van der Graaf, W. T. A., Vaalburg, W., and Hoekstra, H. J. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat. Rev., 1: 83-101, 2004.
33. Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H. J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., and Mangner, T. J. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat. Med., 4: 1334-1336, 1998.
34. [18F]FLT). J. Radiochem. Nucl. Chemistry, 243: 843-846, 2000.
35. Schelbert, H. R., Hoh, C. K., Royal, H. D., Brown, M., Dahlbom, M. N., Dehdashti, F., and Wahl, R. L. Procedure guideline for tumor imaging using fluorine-18-FDG. J. Nucl. Med., 39: 1302-1305, 1998.
36. Lonneux, M., Borbath, I., Bol, A., Coppens, A., Sibomana, M., Bausart, R., Defrise, M., Pauwels, S., and Michel, C. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur. J. Nucl. Med., 26: 591-598, 1999.
37. Fletcher, C. D. M., Unni, K., and Mertens, F. WHO Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002.
38. Coindre, J. M., Terrier, P., Guillou, L., Le Doussal, V., Collin, F., Ranchere, D., Sastre, X., Vilain, M. O., Bonichon, F., and N'Guyen, B. B. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer (Phila.), 91: 1914-1926, 2001.
39. 18F]FLT; portrait of a proliferation marker. Eur. J. Nucl. Med., 29: 165-169, 2002.
40. Sherley, J. L., and Kelly, T. J. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem., 263: 8350-8358, 1988.